Table 2 Clinico-demographic profile of patients based on the severity of COVID-19.
Variables | Total | Non sever | Sever | P-value |
|---|---|---|---|---|
Age | ||||
< 65 yr | 13,139(67.2) | 12,064(70.9) | 1075(42.1) | |
≤ 65 yr | 6422(32.8) | 4941(29.1) | 1481(57.9) | *< 0.001 |
Sex | ||||
Male | 10,291(52.6) | 8893(52.3) | 1398(54.6) | |
Female | 9285(47.4) | 8124(47.7) | 1161(45.4) | *0.025 |
Covid-19 History(yes) | 7514(38.4) | 6407(1.1) | 1107(2.5) | *< 0.001 |
Exposure with a covid-19 patient (yes) | 165(1.3) | 115(37.7) | 50(43.3) | *< 0.001 |
Hospitalization length(days) | 4.87 ± 6.64 | 4.5 ± 6.09 | 7.33 ± 9.14 | *< 0.001 |
Breath rate | ||||
14–18 | 5249(46.9) | 4576(48.2) | 673(39.7) | |
18–22 | 4753(42.5) | 4046(42.6) | 707(41.7) | |
22–28 | 996(8.9) | 773(8.1) | 223(13.1) | |
≥ 28 | 189(1.7) | 95(1) | 94(5.5) | *< 0.001 |
Mean temperature-°C | 37.11 ± 0.74 | 37.1 ± 0.73 | 37.2 ± 0.8 | *< 0.001 |
Symptoms number. (%) | ||||
Fever | 7785(39.8) | 6876(40.4) | 909(30.5) | *< 0.001 |
Cough | 8984(45.9) | 8044(47.3) | 940(36.7) | *< 0.001 |
Dyspnea | 8349(42.6) | 6618(38.9) | 1731(67.6) | *< 0.001 |
Chest pain | 943(5.1) | 840(5.3) | 103(4.1) | 0.012* |
Stomach ache | 687(3.7) | 684(4) | 39(1.6) | < 0.001 |
Nausea | 352(1.8) | 326(1.9) | 26(1) | *0.001 |
Vomiting | 1007(5.4) | 894(5.6) | 113(4.5) | *0.026 |
Diarrhea | 682(3.7) | 630(3.9) | 52(2.1) | *< 0.001 |
Loss of appetite | 2042(11) | 1731(10.8) | 311(12.4) | *0.019 |
Muscular. Pain | 5865(30) | 5296(31.1) | 569(22.2) | *< 0.001 |
Paresis | 132(0.7) | 93(0.6) | 39(1.6) | *< 0.001 |
Plegia | 59(0.3) | 46(0.3) | 13(0.5) | 0.06 |
Vertigo | 500(2.7) | 459(2.9) | 41(1.6) | *< 0.001 |
Seizure | 64(0.3) | 42(0.2) | 23(0.9) | *< 0.001 |
Insomnia | 352(1.8) | 326(1.9) | 26(1) | *0.001 |
Unconsciousness | 872(4.5) | 382(2.2) | 490(19.1) | *< 0.001 |
Headache | 1644(9) | 1509(9.5) | 135(5.4) | *< 0.001 |
Loss appetite | 2042(11) | 1731(10.8) | 311(12.4) | *0.019 |
Smell impairment | 352(1.8) | 326(1.9) | 26(1) | *0.001 |
Taste impairment | 198(1) | 181(1.1) | 17(0.7) | 0.059 |
Skin sign | 30(0.2) | 27(0.2) | 3(0.1) | 0.55 |
GI symptom | 3534(19.1) | 3112(19.4) | 422(16.8) | *0.002 |
Respiratory symptom | 13,950(73.2) | 11,870(71.8) | 2080(82.1) | *< 0.001 |
Nervous system | 157(0.8) | 111(0.7) | 46(1.8) | *< 0.001 |
Comorbidity | ||||
Cardiovascular disease | 1450(7.4) | 1068(6.3) | 382(14.9) | *< 0.001 |
Hypertension | 2236(11.4) | 1715(10.) | 521(20.4) | *< 0.001 |
Diabetes mellitus | 2267(11.6) | 1746(10.3) | 521(20.4) | *< 0.001 |
Cancer | 218(1.1) | 155(0.9) | 63(2.5) | *< 0.001 |
COPD (Chronic Obstructive Pulmonary Disease) | 308(1.6) | 194(1.1) | 114(4.5) | *< 0.001 |
CKD (chronic kidney disease) | 287(1.5) | 212(1.2) | 75(2.9) | *< 0.001 |
Asthma | 170(0.9) | 133(0.8) | 37(1.4) | *0.001 |
Liver disease | 35(0.2) | 30(0.2) | 5(0.2) | 0.8 |
Neurological disorders | 157(0.8) | 111(0.7) | 46(1.8) | *< 0.001 |
Hematology | 55(0.3) | 46(0.3) | 9(0.4) | 0.46 |
HIV | 8(0.0004) | 7(0) | 1(0) | 0.96 |
Congenital disorder | 15(0.1) | 13(0.1) | 2(0.1) | 0.97 |
Pregnancy | 123(0.6) | 121(0.7) | 2(1.6) | *< 0.001 |
Smoking | 359(1.8) | 293(1.4) | 66(2.6) | *0.003 |
Opium | 333(1.7) | 242(1.4) | 91(3.6) | *< 0.001 |
Early diagnosis based on | ||||
Positive PCR | 7828(40) | 6575(38.7) | 1253(49) | |
Abnormal lung CT | 6270(32.1) | 5427(31.9) | 843(33) | |
Clinically admission | 5464(27.9) | 5003(29.4) | 461(18) | *< 0.001 |
Inpatients treatments | ||||
Dialysis (N = 224/393) | 155(54) | 111(52.4) | 44(58.7) | 0.34 |
Chemotherapy | 48(38.7) | 32(34) | 16(53.3) | 0.059 |
Oxygen therapy | 3949(31.2) | 3110(29.1) | 839(42.2) | *< 0.001 |
Hospital outcome | ||||
Death | 1787(9.1) | 819(4.8) | 968(37.8) | |
Recovery | 17,789(90.9) | 16,198(95.2) | 1591(62.2) | *< 0.001 |
